Company Analysis
Sign in

Solid Biosciences Inc. (SLDB)

Nasdaq: SLDB · Biological Products, (No Diagnostic Substances) · Charlestown, MA · filing with the SEC since 2017
Full chart Alerts Compare
Grade4.5
◀ Past 3.0● Present 5.1▶ Future 5.0
3 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2022, as filed
Revenue$8.1M-40.6%
Net income-$86.0M-19.1%
Earnings per share$-10.10+0.4%
Operating cash flow-$98.0M-26.0%
Cash$157M+29.7%
Debtn/a
Shareholders’ equity$212M+1.7%
Shares, diluted8,512,089+19.6%
Return on equity-96.8%
The recordfrom its filings
Filings in 2026107
Newest filingNov 6 · SCHEDULE 13D/A
Annual reportMar 19, 2026
Quarterly reportNov 4, 2026
Next report due10-K by Mar 31
Insider sales, 12 months$2.7M
Insider buys, 12 months$0.00
Patents granted0
Filer categoryNon-accelerated filer<br>Smaller reporting company
Trailing twelve months to Sep 2026Net income -$215MCash from operations -$199Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
16171819202122232425
As filed, in USD. Nothing here is a forecast.

News

Nov 4, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
Oct 26, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 20, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 6, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Aug 6, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Aug 6, 2026 · SEC EDGAR · Form 424B5
Shelf offering
Open the filing on sec.gov
Aug 6, 2026 · SEC EDGAR · Form S-3ASR
Shelf registration
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton SLDB · research, not advice